Fmoc-Lys(Boc)-OH-13C6,15N2

Modify Date: 2024-01-09 09:18:48

Fmoc-Lys(Boc)-OH-13C6,15N2 Structure
Fmoc-Lys(Boc)-OH-13C6,15N2 structure
Common Name Fmoc-Lys(Boc)-OH-13C6,15N2
CAS Number 850080-89-6 Molecular Weight 476.48
Density 1.2±0.1 g/cm3 Boiling Point N/A
Molecular Formula C2013C6H3215N2O6 Melting Point N/A
MSDS Chinese USA Flash Point N/A
Symbol GHS09
GHS09
Signal Word Warning

 Use of Fmoc-Lys(Boc)-OH-13C6,15N2


Fmoc-L-Lys (Boc)-OH-13C6,15N2 is a 15N-labeled and 13C-labled Triclabendazole.

 Names

Name Fmoc-Lys(Boc)-OH-13C6,15N2
Synonym More Synonyms

 Fmoc-Lys(Boc)-OH-13C6,15N2 Biological Activity

Description Fmoc-L-Lys (Boc)-OH-13C6,15N2 is a 15N-labeled and 13C-labled Triclabendazole.
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[75].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-243.

[2]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-243.

 Chemical & Physical Properties

Density 1.2±0.1 g/cm3
Molecular Formula C2013C6H3215N2O6
Molecular Weight 476.48
Exact Mass 476.24000
PSA 113.96000
LogP 5.45510
Index of Refraction 1.566

 Safety Information

Symbol GHS09
GHS09
Signal Word Warning
Hazard Statements H410
Precautionary Statements P273-P501
Personal Protective Equipment Eyeshields;Gloves
RIDADR UN 3077 9 / PGIII

 Synonyms

L-Lysine-13C6-15N2, N6-[(1,1-dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-
N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N6-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-(13C6,15N2)lysine
N6-(tert-Butoxycarbonyl)-N2-{[(9H-fluoren-9-yl)methoxy]carbonyl}-L-(13C6,15N2)lysine